Personalis, Inc. Cost, Maintenance
Personalis, Inc. (PSNL) reported Cost, Maintenance of $2.82 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostMaintenance · last filed 2026-08-04
- Personalis, Inc. cost, maintenance for the quarter ending 2026-06-30 was $2.82M, a 37.57% increase year-over-year.
- Personalis, Inc. cost, maintenance for the quarter ending 2026-03-31 was $2.62M, a 38.14% increase year-over-year.
- Personalis, Inc. cost, maintenance for the quarter ending 2025-12-31 was $2.43M, a 6.26% increase year-over-year.
- Personalis, Inc. cost, maintenance for the quarter ending 2025-09-30 was $2.44M, a 17.58% increase year-over-year.
- Personalis, Inc. cost, maintenance for fiscal 2025 was $8.81M, a 7.28% increase from fiscal 2024.
- Personalis, Inc. cost, maintenance for fiscal 2024 was $8.21M, a 3.17% decline from fiscal 2023.
- Personalis, Inc. cost, maintenance for fiscal 2023 was $8.48M.
| Period end | Cost, Maintenance 3 month | Cost, Maintenance 6 month | Cost, Maintenance 9 month | Cost, Maintenance 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.82M 10-Q · filed 2026-08-04 | $5.37M 10-Q · filed 2026-08-04 | $7.86M derived: sum of 3 quarters · filed 2026-08-04 | $10.30M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $2.62M 10-Q · filed 2026-05-07 | $5.04M derived: sum of 2 quarters · filed 2026-05-07 | $7.48M derived: sum of 3 quarters · filed 2026-05-07 | $9.53M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.87M derived: sum of 2 quarters · filed 2026-02-26 | $6.92M derived: sum of 3 quarters · filed 2026-08-04 | $8.81M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.44M 10-Q · filed 2025-11-04 | $4.49M derived: sum of 2 quarters · filed 2026-08-04 | $6.38M 10-Q · filed 2025-11-04 | $8.66M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $2.05M 10-Q · filed 2026-08-04 | $3.94M 10-Q · filed 2026-08-04 | $6.22M derived: sum of 3 quarters · filed 2026-08-04 | $8.30M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $1.89M 10-Q · filed 2026-05-07 | $4.18M derived: sum of 2 quarters · filed 2026-05-07 | $6.25M derived: sum of 3 quarters · filed 2026-05-07 | $7.98M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $2.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.36M derived: sum of 2 quarters · filed 2026-02-26 | $6.09M derived: sum of 3 quarters · filed 2026-02-26 | $8.21M 10-K · filed 2026-02-26 |
| 2024-09-30 | $2.08M 10-Q · filed 2025-11-04 | $3.81M derived: sum of 2 quarters · filed 2025-11-04 | $5.93M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $1.73M 10-Q · filed 2025-08-05 | $3.85M 10-Q · filed 2025-08-05 | ||
| 2024-03-31 | $2.12M 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $8.48M 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |